Rapid Benzodiazepine Detoxification Using Flumazenil - 1

Phase 2

Completed

• Conditions: Substance-Related Disorders

• Registration Number: NCT00000246
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.

Detailed Description

Not available

Study Timeline

• Study Start: 1993-01
• Primary Completion: 1994-12
• Study Completion: 1994-12
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-06
• Last Update Posted: 2016-09-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Benzodiazepine withdrawal severity

Trial Locations

Locations (1)

Yale University, Psychiatry; 🇺🇸 New Haven, Connecticut, United States